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Abstract
Background: The presentation and causes of adult meningitis in South Africa have changed substantially as a
result of HIV. Knowledge of aetiology and laboratory findings in patients presenting with meningitis are important
in guiding management. We performed a retrospective study to determine these findings in a setting of high HIV
and TB prevalence in Cape Town.
Methods: Patients undergoing lumbar punctures between 1
st January 2006 and 31
st December 2008 at a public
sector referral hospital were studied. Cases were classified by microbiological diagnosis, or in the absence of
definitive microbiology as 1) normal CSF (neutrophils ≤ 1×1 0
6/L, lymphocytes ≤ 5×1 0
6/L, protein ≤ 0.5 g/dL,
glucose ≥1.5 mmol/L), 2) minor abnormalities (neutrophils 2-5, lymphocytes 6-20, protein 0.51-1.0, glucose 1.0-1.49)
or 3) markedly abnormal (neutrophils>5, lymphocytes>20, protein>1.0, glucose<1.0).
Results: 5578 LPs were performed on 4549 patients, representing 4961 clinical episodes. Of these, 2293 had
normal CSF and 931 had minor abnormalities and no aetiology identified. Of the remaining 1737, microbiological
diagnoses were obtained in 820 (47%). Cryptococcus accounted for 63% (514) of microbiological diagnoses, TB for
28% (227), bacterial meningitis for 8% (68). Of the remaining 917 who had marked abnormalities, the majority
(59%) had a sterile lymphocytic CSF. Of note 16% (81) patients with confirmed Cryptococcus, 5% (12) with TB and
4% (3) with bacterial meningitis had normal CSF cell-counts and biochemistry.
Conclusions: Cryptococcal and tuberculous meningitis are now the commonest causes of adult meningitis in this
setting. TB meningitis is probably underdiagnosed by laboratory investigation, as evidence by the large numbers
presenting with sterile lymphocytic markedly abnormal CSFs.
Background
South Africa has the highest burden of human immuno-
deficiency virus (HIV) disease in the world, with an esti-
mated 5.5 million cases accounting for 17% of the global
total [1]. This is associated with one of the world’s high-
est tuberculosis (TB) incidence rates [1]. The presenta-
tion and causes of adult meningitis have changed
substantially as a result of these ongoing epidemics
[2,3]. Advanced HIV-infection can make interpretation
of both clinical and laboratory findings difficult, hence
knowledge of aetiology and laboratory findings in
patients presenting with meningitis are important in
guiding management. We performed a retrospective
study to determine these findings in a setting of high
HIV and tuberculosis prevalence in Cape Town.
Methods
The study was approved by the Research Ethics Com-
mittee of the University of Cape Town, and performed
at GF Jooste Hospital, a public sector adult referral hos-
pital serving a population of 1.3 million. Forty-three per-
cent of patients admitted to the medical wards have
proven or clinically suspected HIV [4], and TB incidence
in the referral area exceeds 1000/100,000 person-years
[5].
Participants and procedures
Patients undergoing lumbar-punctures (LPs) between 1
st
January 2006 and 31
st December 2008 were studied.
Results of all LPs performed for any indication were
recorded, the majority being for suspected meningitis in
acute admissions, with demographic information from
laboratory request forms and clinical notes. Cerebrosp-
inal-fluid (CSF) samples underwent macroscopic
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counts using a Neubauer counting chamber following
crystal violet staining, Gram-staining of centrifuged sedi-
ment, and bacterial culture on blood and chocolate agar
for 72 hours. India-ink staining of centrifuged CSF,
cryptococcal antigen (CrAg) testing (Meridian Crypto-
coccal Latex Agglutination System, Meridian Bioscience)
if India-ink negative, and fungal culture of all samples
on potato dextrose agar (PDA) slopes for 14 days were
carried out. TB microscopy (Auramine-flourescent stain
of the sediment when sufficient sample), liquid culture
in mycobacterial growth indicator tubes (MGIT, Becton-
Dickenson), Lowenstein-Jensen agar slopes if sufficient
sample, and TB-PCR (Genotype MTBDRplus, Hain Life-
sciences) on positive culture samples from MGIT were
performed in cases of suspected TB meningitis (TBM)
at the clinician’s request, or when CSF findings were
suggestive of TBM. In a limited number of cases TB-
PCR was performed directly on CSF samples in an effort
to rapidly obtain drug susceptibility data. VDRL and
TPHA testing were carried out at the clinician’s request.
Evaluation and outcomes
When a patient had more than one LP, a separate clini-
cal episode was defined when there was ≥1m o n t h
between LPs, except in cases of TBM, where any repeat
LP within 6 months was considered part of the same
episode. These definitions were based on the best avail-
able evidence, and aimed to reflect the total burden of
meningitis due to differing aetiologies, including relapse
episodes. Median duration of admission for cryptococcal
meningitis at our hospital is 15 days, with an inter-quar-
tile range (IQR) of 13 to 20 days (unpublished data). For
TB meningitis a cut-of off 6 months was chosen, as
patients are treated with 6-9 months of therapy, and the
TB programme regards a re-presentation with TBM
during treatment as a deterioration of the initial episode,
rather than a “recurrence” or “relapse”.
Cases were classified by microbiological diagnosis, or
in the absence of definitive microbiology as:
1) normal CSF (neutrophils ≤ 1×1 0
6/L, lymphocytes
≤ 5×1 0
6/L, protein ≤ 0.5 g/dL, and glucose ≥1.5
mmol/L with no organism isolated),
2) minor abnormalities (neutrophils 2-5 × 10
6/L, lym-
phocytes 6-20 × 10
6/L, protein 0.51-1.0 g/dL, or glucose
1.0-1.49 mmol/L and no organism isolated) or
3) markedly abnormal (neutrophils>5 × 10
6/L, lym-
phocytes>20 × 10
6/ L ,p r o t e i n > 1 . 0g / d L ,o rg l u c o s e < 1 . 0
mmol/L and no organism isolated).
Markedly abnormal cases were further classified into
lymphocytic (lymphocyte predominance, LØ:NØ ratio
≥3:1), mixed (LØ:NØ ratio between 3 and 0.33), and pyo-
genic (neutrophil predominance, NØ:LØ ratio ≥3:1).
HIV status was determined for all patients with micro-
biologically confirmed disease during the last 2 years of
the study from laboratory records and clinical notes.
Results
Over the 3-year study period 5578 LPs were performed
on 4549 patients, representing 4961 clinical episodes.
Forty-three percent of patients were male, and the med-
ian age was 34 years. Of these 4961 clinical episodes,
2293 had a normal CSF and no microbiological diagno-
sis. A further 931 episodes had minor abnormalities and
no aetiology identified, compatible with the pleocytosis
seen in HIV infection. Of the remaining 1737 episodes,
microbiological diagnoses were obtained in 820 (47%).
See figure 1.
CSF findings
Cryptococcus (CM) accounted for 63% (514) of micro-
biological diagnoses, 93 (18%) of which were relapses of
previously treated episodes. The CM relapse episodes
occurred a median of 92 days after the initial episode
(IQR 56-131 days). TB accounted for 28% (227), bacter-
ial meningitis for 8% (68) and neurosyphillis for 3% (22)
(figure 1). There were 2 patients who had 2 distinct epi-
sodes of TBM, one occurring 7 months and one occur-
ring 10 months after the initial episode. CM was
initially diagnosed on India-ink staining in 60% of cases,
and CrAg testing in 40%. Cultures were positive in 68%.
Laboratory confirmation of TBM was almost exclusively
by culture, with smear positive microscopy in only 3 of
the 227 cases. Of the culture confirmed bacterial
meningitis, Streptococcus pneumoniae accounted
for 90% (57 of 64), and Neisseria meningitides 3% (2 of
64). Gram-staining was positive in 58 (85%) of the
68 patients.
Of the 917 cases with markedly abnormal CSF and no
microbiological diagnosis, 539 (59%) had a lymphocytic
predominance, 114 (12%) a mixed picture, 75 (8%) a
polymorph predominance and 189 (21%) a normo-cellu-
lar picture with abnormal protein and/or glucose.
Of note 16% (81) patients with confirmed CM, 5%
(12) with TBM and 4% (3) with bacterial meningitis had
normal CSF cell counts, protein and glucose (table 1).
HIV status
During the last two years of the study period HIV status
was ascertained for all but 2 of the CM patients (n =
339), of whom 99% (337) were HIV positive, median
CD4 cell count of 39 cells/μL; 134 of 158 TBM patients,
94% (126) of whom were HIV positive, median CD4 cell
count 126 cells/μL; and 30 of the 46 bacterial meningitis
cases, of whom 97% (29) were HIV positive, median
CD4 cell count 287 cells/μL.
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This is the largest reported series of adult meningitis in
South Africa. CM and TBM are the commonest causes
of adult meningitis in our setting (63% and 27% of
microbiological diagnoses respectively). This is in
marked contrast to the pre-HIV era [6,7], and in keep-
ing with recent data from central and southern Africa
showing that cryptococcosis is now the leading cause of
adult meningitis, accounting for 27-45% of all cases
[2,3,8-11]. As in these previously reported series, CM in
our study was almost exclusively in the context of
advanced HIV disease. Of note, during the study period
approximately one third of initial episodes of CM
occurred in patients already on ART [12], so that both
initial and relapse episodes of CM were a mix of
patients on and not on ART. This may explain why the
proportion of cases diagnosed on India Ink and culture
were lower, and those diagnosed by CrAg higher, than
prior series, and also why CSF indices did not differ
between initial and relapse episodes.
The proportion of TBM in our study was higher than
in most reported cohorts from central and southern
Figure 1 CSF findings in the 4961 episodes, and aetiology of the 820 cases with a confirmed microbiological diagnosis.
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Page 4 of 6Africa, which range from 1-17% [2,3,8,10], however simi-
lar to figures from two small South African studies. TBM
accounted for 25.4% of all adult meningitis in Soweto in
1996 [13], and increased from 16% in 1994 to 31% in
1998 in Pretoria [14]. The proportion of TBM in our
study is almost certainly an under-estimate. TBM is
under-diagnosed by routine laboratory investigation, with
reported rates of microbiological confirmation ranging
from 25 to 70% [15]. In a recent Vietnamese study,
microbiological confirmation of TBM was obtained in
45% of HIV-positive patients, versus 33% of HIV-negative
patients [16]. Assuming similar confirmation rates in our
setting, it is likely that a substantial number of the 539
cases with no microbiological diagnosis, and lymphocytic
CSF, represented TBM; an assumption supported by the
very high community TB rates in our setting [5].
Further reasons for possible under-diagnosis of TBM
were that not all CSF samples were sent for TB studies,
volumes of CSF examined were low (typically 1-2 mls),
and time for smear microscopy was limited. There is
good evidence that diagnostic yields can be improved by
collection of large CSF volumes for culture, and careful
microscopic examination of centrifuged samples [17,18].
Smear positivity rates of 58-69% have been reported
from Vietnam, where up to 10 mls of CSF was routinely
obtained [17,18], and efforts are needed to improve the
diagnosis of TBM in our setting.
Numbers of bacterial meningitis were relatively low. It
is possible that prior antibiotic exposure hindered diag-
nosis in some cases, however numbers of sterile pyo-
genic CSFs were low. Numbers of bacterial meningitis
appear to have stayed more or less constant despite the
evolving HIV epidemic [14], but with a marked switch
in aetiology. Meningococcus, which previously predomi-
nated, causing ~30% of adult bacterial meningitis [6,7],
accounted for only 3% in our series, with Pneumococcus
accounting for over 90% of bacterial meningitis.
The study highlights the fact that HIV co-infection, as
well as changing the causative organisms, can lead to
atypical laboratory presentations of meningitis. Substan-
tial numbers of patients with CM, TB and bacterial
meningitis had normal or nearly normal CSF findings.
Of particular note were the findings in bacterial menin-
gitis, almost all of which was HIV-associated. Four (6%)
of 68 patients had acellular CSF, 30 (44%) of 68 had a
lymphocyte predominance, and the majority had very
elevated CSF protein. This adds to the diagnostic diffi-
culties posed by the often overlapping clinical features
of meningitis a population with a high HIV prevalence,
further compounded by the presence of dual pathology
in a small proportion of cases (table).
A limitation is that, as a laboratory based study,
detailed clinical information was lacking. CM is unlikely
to be missed, however, as discussed, TBM is likely to
under-diagnosed by laboratory investigation, and this
caveat must be taken into account when interpreting
these data.
Conclusions
The HIV and TB epidemics in South Africa have led to
a marked change in the aetiology of adult meningitis.
Cryptococcus has emerged as the dominant causative
agent, the proportion of meningitis due to TB is increas-
ing, and the spectrum of bacterial meningitis has been
markedly altered. High rates of HIV in a population
may make interpretation of CSF findings difficult, and it
is important to take these data into account when inves-
tigating and managing patients with suspected meningi-
tis. Mortality of both cryptococcal and TB meningitis
remains high in this setting [11,18], and these results
underscore the importance of continuing efforts to
improve the early diagnosis and treatment of cryptococ-
cal and TB meningitis.
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